There has been an outstanding improvement in the life expectancy of HIV patients followed 1996 to 2005-largely related to the development and use of combination antiretroviral therapies. This was a large group study of U.S. patients, over 220,000. positive HIV patients were followed. At the end of 2007, 10,366 patients had died.
The following excerpt regarding study specifics was pulled from "Journal Watch" - www.jwatch.org:
Average life expectancy from the time of diagnosis increased by 12 years during the study period — from 10.5 years in 1996 to 22.5 years in 2005. The greatest annual increase was seen between 1996 and 1997, following the introduction of potent ART, but smaller increases have been seen almost every year since. Throughout the study period, life expectancy was greater for women than for men (23.6 vs. 22.0 years in 2005) and was worst for injection-drug users (15.2 in 2005). Racial/ethnic disparities were evident, particularly among men: In 2005, life expectancy was 25.5 years for whites, 22.6 years for Hispanics, and 19.9 years for blacks. Among women, life expectancy was 21.4 years for whites, 24.2 years for blacks, and 21.2 years for Hispanics.
Underwriting Term du Jour: ART-antiretroviral therapy
Come visit me at:
www.linkedin.com/in/tddavisaus
www.advanceduwsolutions.com
http://twitter.com/TraciDavisAUS
No comments:
Post a Comment